No data available for this ticker
UP.BK Probability of Bankruptcy
The Probability of Bankruptcy of (UP.BK) is 0% . This number represents the probability that UP.BK will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating UP.BK's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
UP.BK - Historical Solvency Measures
to of
Page of
UP.BK - ESG ratings
ESG ratings are directly linked to the cost of capital and UP.BK's ability to raise funding, both of which can significantly affect the probability of going bankrupt.
ESG Score
0
Environment Score
0
Social Score
0
Governance Score
0
| Returns | |
| Historical Returns (5 day) | 1.75% |
| Historical Returns (MTD) | 2.96% |
| Historical Returns (YTD) | -0.57% |
| Historical Returns (13 week) | 4.19% |
| Historical Returns (26 week) | 0.58% |
| Historical Returns (52 week) | -25.57% |
| Efficiency | |
| Asset Turnover | 0.82 |
| Receiveable Turnover | 8.7 |
| Gross Margin | 6.7% |
| Operating Margin | 7.2% |
| Pretax Margin | 8% |
| Net Margin | 8% |
| Return on Asset (ROA) | 6.56 |
| Return on Equity (ROE) | 8.15 |
| Return on Investments (ROI) | 8.13 |
| Price Metrics | |
| Market Cap (M) | - |
| Enterprise Value (M) | - |
| 52 Week High | 22 |
| 52 Week Low | 16 |
| Beta | 0.55 |
| Average Volume (10 day) | 0 |
| Average Volume (3 month) | 0.01 |
| Price / Earnings (P/E) | 8.7 |
| Price / Sales (P/S) | 0.7 |
| Earnings | |
| EPS | 2 |
| Revenue CAGR (5 year) | -1.16% |
| Risk | |
| Current Ratio | 4.34 |
| Quick Ratio | 3.94 |
UP.BK - Peer Comparisons
| Ticker | Company Name | Beta | Probability of Bankruptcy |
| a | |||
| GERN | Geron Corp | 1.52 | 47.3% |
| APLT | Applied Therapeutics Inc | 0.94 | 47.5% |
| FHTX | Foghorn Therapeutics Inc. | 1.65 | 48.9% |
| INZY | Inozyme Pharma Inc | 1.31 | 76.1% |
| SMMT | Summit Therapeutics Inc | 3.86 | 34.2% |